» Articles » PMID: 26511680

Bakkenolide-IIIa Protects Against Cerebral Damage Via Inhibiting NF-κB Activation

Overview
Specialties Neurology
Pharmacology
Date 2015 Oct 30
PMID 26511680
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: This study was designed to examine the neuroprotective effects of bakkenolide-IIIa, a major novel compound extracted from the rhizome of P. trichinous.

Methods: Transient focal cerebral damage model in rats and oxygen-glucose deprivation (OGD) in cultured hippocampal neurons were performed. The amount of apoptotic neurons was determined using TUNEL assay. The expressions of Bcl-2, Bax, Akt, ERK1/2, IKKβ, IκBα were measured using Western blot. The nuclear translocation and activation of NF-κB was measured using a fluorescence microscope and electrophoretic mobility shift assay (EMSA).

Results: Bakkenolide-IIIa (4, 8, 16 mg/kg; i.g.) was administered immediately after reperfusion could reduce the brain infarct volume, and the neurological deficit, as well as a high dose of bakkenolide-IIIa, increases the 72 h survival rate in cerebrally damaged rats. In vitro data demonstrated that bakkenolide-IIIa could increase cell viability and decrease the amount of apoptotic cells in cultured primary hippocampal neurons exposed to OGD. Bakkenolide-IIIa also dose-dependently increased the ratio of Bcl-2 to Bax. These results indicated that inhibition of apoptosis partly mediated the neuroprotection of bakkenolide-IIIa. Furthermore, bakkenolide-IIIa inhibited the phosphorylation of Akt, ERK1/2, IKKβ, IκBα, and p65 in cultured hippocampal neurons exposed to OGD. Bakkenolide-IIIa not only inhibited the nuclear translocation of NF-κB in cultured neurons exposed to OGD, but also inhibited the activation of NF-κB in peri-infarct area in cerebrally damaged rats.

Conclusion: Collectively, our findings indicated that bakkenolide-IIIa protects against cerebral damage by inhibiting AKT and ERK1/2 activation and inactivated NF-κB signaling.

Citing Articles

A short peptide exerts neuroprotective effects on cerebral ischemia-reperfusion injury by reducing inflammation via the miR-6328/IKKβ/NF-κB axis.

Li Y, Jin T, Liu N, Wang J, Qin Z, Yin S J Neuroinflammation. 2023; 20(1):53.

PMID: 36855153 PMC: 9972639. DOI: 10.1186/s12974-023-02739-4.


Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications.

Xu H, Wang E, Chen F, Xiao J, Wang M Oxid Med Cell Longev. 2021; 2021:6687386.

PMID: 34007405 PMC: 8102108. DOI: 10.1155/2021/6687386.


Bakkenolide‑IIIa ameliorates lipopolysaccharide‑induced inflammatory injury in human umbilical vein endothelial cells by upregulating LINC00294.

Xu J, Feng H, Ma L, Tan H, Yan S, Fang C Mol Med Rep. 2021; 23(5).

PMID: 33760129 PMC: 7986008. DOI: 10.3892/mmr.2021.12016.


Lycopene Exerts Neuroprotective Effects After Hypoxic-Ischemic Brain Injury in Neonatal Rats via the Nuclear Factor Erythroid-2 Related Factor 2/Nuclear Factor-κ-Gene Binding Pathway.

Fu C, Zheng Y, Zhu J, Chen B, Lin W, Lin K Front Pharmacol. 2021; 11:585898.

PMID: 33390957 PMC: 7774511. DOI: 10.3389/fphar.2020.585898.


Electroacupuncture Reduced Apoptosis of Hippocampal Neurons in Mice with Cerebral Infarction by Regulating the Notch3 Signaling Pathway.

Tian R, Wang S J Mol Neurosci. 2019; 67(3):456-466.

PMID: 30726543 DOI: 10.1007/s12031-018-1253-5.

References
1.
Krappmann D, Hatada E, Tegethoff S, Li J, Klippel A, Giese K . The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J Biol Chem. 2000; 275(38):29779-87. DOI: 10.1074/jbc.M003902200. View

2.
Crack P, Taylor J . Reactive oxygen species and the modulation of stroke. Free Radic Biol Med. 2005; 38(11):1433-44. DOI: 10.1016/j.freeradbiomed.2005.01.019. View

3.
Benes V, Netuka D, Charvat F, Mohapl M . Recanalization of long-lasting middle cerebral artery occlusion by a combination of surgical and interventional approaches: technical case report. Neurosurgery. 2005; 57(4 Suppl):E401. DOI: 10.1227/01.neu.0000176853.98516.4e. View

4.
Won S, Kim D, Gwag B . Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol. 2005; 35(1):67-86. DOI: 10.5483/bmbrep.2002.35.1.067. View

5.
Lopez-Neblina F, Toledo A, Toledo-Pereyra L . Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg. 2005; 18(6):335-50. DOI: 10.1080/08941930500328862. View